Mechanism of Three-Component Collision to Produce Ultrastable pRNA Three-Way Junction of Phi29 DNA-Packaging Motor by Kinetic Assessment by Binzel, Daniel W. et al.
University of Kentucky
UKnowledge
Nanobiotechnology Center Faculty Publications Nanobiotechnology
11-2016
Mechanism of Three-Component Collision to
Produce Ultrastable pRNA Three-Way Junction of
Phi29 DNA-Packaging Motor by Kinetic
Assessment
Daniel W. Binzel
University of Kentucky, daniel.binzel@uky.edu
Emil F. Khisamutdinov
University of Kentucky, emil.k@uky.edu
Mario Vieweger
University of Kentucky, mario.vieweger@uky.edu
Janice Ortega
University of Kentucky, jorte2@uky.edu
Jingyuan Li
Chinese Academy of Sciences, China
See next page for additional authors
Right click to open a feedback form in a new tab to let us know how this document benefits you.
Follow this and additional works at: https://uknowledge.uky.edu/nanobio_facpub
Part of the Pharmacy and Pharmaceutical Sciences Commons
This Article is brought to you for free and open access by the Nanobiotechnology at UKnowledge. It has been accepted for inclusion in
Nanobiotechnology Center Faculty Publications by an authorized administrator of UKnowledge. For more information, please contact
UKnowledge@lsv.uky.edu.
Repository Citation
Binzel, Daniel W.; Khisamutdinov, Emil F.; Vieweger, Mario; Ortega, Janice; Li, Jingyuan; and Guo, Peixuan, "Mechanism of Three-
Component Collision to Produce Ultrastable pRNA Three-Way Junction of Phi29 DNA-Packaging Motor by Kinetic Assessment"
(2016). Nanobiotechnology Center Faculty Publications. 4.
https://uknowledge.uky.edu/nanobio_facpub/4
Authors
Daniel W. Binzel, Emil F. Khisamutdinov, Mario Vieweger, Janice Ortega, Jingyuan Li, and Peixuan Guo
Mechanism of Three-Component Collision to Produce Ultrastable pRNA Three-Way Junction of Phi29 DNA-
Packaging Motor by Kinetic Assessment
Notes/Citation Information
Published in RNA, v. 22, 11, p. 1710-1718.
© 2016 Binzel et al.; Published by Cold Spring Harbor Laboratory Press for the RNA Society
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication
date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml). After 12 months, it is available under a
Creative Commons License (Attribution-NonCommercial 4.0 International), as described at
http://creativecommons.org/licenses/by-nc/4.0/.
Digital Object Identifier (DOI)
https://doi.org/10.1261/rna.057646.116
This article is available at UKnowledge: https://uknowledge.uky.edu/nanobio_facpub/4
Mechanism of three-component collision to produce
ultrastable pRNA three-way junction of Phi29
DNA-packaging motor by kinetic assessment
DANIEL W. BINZEL,1,2 EMIL KHISAMUTDINOV,3,6 MARIO VIEWEGER,1,2 JANICE ORTEGA,4,7 JINGYUAN LI,5
and PEIXUAN GUO1,2
1Division of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, 2Department of Physiology and Cell Biology, College of Medicine,
The Ohio State University, Columbus, Ohio 43210, USA
3Nanobiotechnology Center, Markey Cancer Center, and Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky,
Lexington, Kentucky 40536, USA
4Department of Toxicology and Cancer Biology, University of Kentucky College of Medicine, Lexington, Kentucky 40536, USA
5Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China, 1000049
ABSTRACT
RNA nanotechnology is rapidly emerging. Due to advantageous pharmacokinetics and favorable in vivo biodistribution, RNA
nanoparticles have shown promise in targeted delivery of therapeutics. RNA nanotechnology applies bottom-up assembly, thus
elucidation of the mechanism of interaction between multiple components is of fundamental importance. The tendency of
diminishing concern about RNA instability has accelerated by the finding of the novel thermostable three-way junction (3WJ)
motif of the phi29 DNA-packaging motor. The kinetics of these three components, each averaging 18 nucleotides (nt), was
investigated to elucidate the mechanism for producing the stable 3WJ. The three fragments coassembled into the 3WJ with
extraordinary speed and affinity via a two-step reaction mechanism, 3WJb + 3WJc↔ 3WJbc + 3WJa↔ 3WJabc. The first step of
reaction between 3WJb and 3WJc is highly dynamic since these two fragments only contain 8 nt for complementation. In the
second step, the 3WJa, which contains 17 nt complementary to the 3WJbc complex, locks the unstable 3WJbc complex into a
highly stable 3WJ. The resulting pRNA-3WJ is more stable than any of the dimer species as shown in the much more rapid
association rates and slowest dissociation rate constant. The second step occurs at a very high association rate that is difficult
to quantify, resulting in a rapid formation of a stable 3WJ. Elucidation of the mechanism of three-component collision in
producing the ultrastable 3WJ proves a promising platform for bottom-up assembly of RNA nanoparticles as a new class of
anion polymers for material science, electronic elements, or therapeutic reagents.
Keywords: RNA nanotechnology; nanobiotechnology; bacteriophage; phi29; RNA nanoparticle; viral DNA packaging motor
INTRODUCTION
The field of RNA nanotechnology has recently undergone
rapid expansion mainly due to the fact that RNA has the sim-
plicity characteristic of DNA yet the versatile functionality of
proteins (Masquida et al. 1997; Guo et al. 1998; Lilley 2000;
Leontis and Westhof 2003; Lescoute and Westhof 2006;
Guo 2010; Bindewald et al. 2011; Ye et al. 2012). With the
combination of the advantage of these two materials,
RNA can easily be designed and constructed through bot-
tom-up assembly and plays diverse roles (Felden et al.
1996; Chworos et al. 2004; Shu et al. 2004; Khaled et al.
2005; Jaeger and Chworos 2006; Afonin et al. 2008). The
wide-ranging functionalities of RNA make it a prime candi-
date for applications in sensing operates, computer parts
(Rinaudo et al. 2007; Breaker 2008; Win and Smolke 2008;
Benenson 2009; Xie et al. 2010, 2011; Qiu et al. 2013; Shu
et al. 2014a), imaging reagents (Calzada et al. 2012; Chen
et al. 2012; Paige et al. 2012; Kellenberger et al. 2013),
NEM devices (Noy 2011), and therapeutics including the
delivery, specific targeting, and treatment of cancer and viral
infections (Guo et al. 1998; Shu et al. 2003, 2004, 2011a,
2013; Yingling and Shapiro 2007; Severcan et al. 2009; Afonin
et al. 2011; Chang et al. 2012; Delebecque et al. 2012; Haque
et al. 2012; Lee et al. 2012, 2015b; Tabernero et al. 2013). The
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use of RNA as a delivery vehicle provides several benefits over
other systems and technologies. Firstly, RNA nanoparticles
can be produced with known stoichiometry and high repro-
ducibility (Guo et al. 1998; Lilley 2000; Shu et al. 2004, 2011a;
Afonin et al. 2010; Jasinski et al. 2014; Khisamutdinov et al.
2014a,b), as RNA is composed of simple building blocks
with predictable secondary structure. RNA aptamers can be
used for specific targeting of cell groups through binding to
cell surface receptors much like a protein ligand or antibody
(Cerchia et al. 2009; Abdelmawla et al. 2011; Shu et al.
2011b). Furthermore, the replacement of protein-targeting
reagents with nucleic acids prevents the induction of anti-
bodies (Abdelmawla et al. 2011; Guo et al. 2012; Shu et al.
2014b), allowing for repeated administration. RNA nanopar-
ticles are typically between 10 and 50 nanometers in size,
meaning they are retained in the human body yet are small
enough to pass through cell membranes through endocytosis
(Maeda 2001; Gao et al. 2005; Jain 2005; Li and Szoka 2007;
Maeda et al. 2013; Jasinski et al. 2014; Khisamutdinov et al.
2014b). In in vivo testing, RNA nanoparticles have shown fa-
vorable pharmacokinetic and biodistribution properties, as
they are able to avoid accumulation in healthy organs and tis-
sues with efficient retention in tumors (Shu et al. 2011a;
Haque et al. 2012). Additionally, RNA possess unique in
vivo attributes: (i) transcription, termination, splicing, and
processing allow for in vivo RNA production; (ii) ribos-
witches (Mulhbacher et al. 2010) and ribozymes (Sarver
et al. 1990; Hoeprich et al. 2003; Lilley 2003; Winkler et al.
2004; Liu et al. 2007) result in in vivo processing and possible
assembly into nanoparticles in cell for special functions such
as intracellular computation (Rinaudo et al. 2007; Breaker
2008; Win and Smolke 2008; Benenson 2009; Xie et al.
2010, 2011; Qiu et al. 2013; Shu et al.
2014a); (iii) RNA can self-assemble with-
out external forces (Shu et al. 2014a); and
(iv) RNA is stable in acidic environments
allowing for survival in endosome (Guo
et al. 2012). Even with these advantages,
RNA nanotechnology still has many hur-
dles that it must overcome in order to be
used in therapeutics. Most notably, RNA
is known to have stability issues and is
prone to degradation by RNase that has
since been solved through backbone
modifications, such as 2′-fluoro (Pieken
et al. 1991; Liu et al. 2011), 2′-O-methyl
(Czauderna et al. 2003), or locked nu-
cleotides (Kaur et al. 2006). The dis-
sociation of the self-assembled RNA
nanoparticles at low concentrations and
elevated temperatures in in vivo environ-
ments makes it obligatory to address the
dynamics and kinetics of RNA nanopar-
ticle assembly (Privalov and Filiminov
1978; Freier et al. 1986; Jaeger et al.
1993; Kawasaki et al. 1993; Lesnik and Freier 1995; Sugimoto
et al. 1995; Gyi et al. 1996; Diamond et al. 2001; Brunel et al.
2002).
Recently, a novel ultrastable RNA motif was found in the
packaging RNA (pRNA) of the phi29 dsDNA packaging mo-
tor (Fig. 1) that has since diminished the concerns of RNA
nanoparticles dissociating at low concentrations found in
vivo because of its unusually high thermostability (Shu
et al. 2011a). This motif is a three-way junction (3WJ) that
serves as the central core structure of the pRNA and connects
the helical domain (Zhang et al. 1994) with the two interlock-
ing looped regions of the pRNA (Reid et al. 1994). It has been
determined that the 3WJ serves as the central folding domain
and provides the overall high stability seen in pRNA. The
motif can be formed from three individual RNA oligos at a
high yield even in the absence of metal ions (Shu et al.
2011a). The novelty behind this RNA structure is in the
ease of formation, a remarkably low Gibbs free energy
(ΔG°) of −28 kcal/mol, and a high melting temperature
(Tm) of 59.3°C (Binzel et al. 2014). Furthermore, it has
been proven that the pRNA-3WJ allows the inclusion of
RNA functional moieties such as receptor-binding aptamer,
siRNA, ribozyme, miRNA, or riboswitch, resulting in the
production of functional nanoparticles (Shu et al. 2011a;
Lee et al. 2015a; Rychahou et al. 2015). The addition of func-
tional groups did not interfere with the proper folding of the
3WJ or the added functional moieties. Previously, attempts
have been made to elucidate the mechanism for the kinetic
stability of the pRNA-3WJ, yet the 3WJ was found to be
too stable to detect its dissociation by the current technology
of radioactive chasing (Shu et al. 2011a). However, thermo-
dynamic studies were previously completed on the pRNA-
FIGURE 1. Overview of the Phi29 pRNA and the three-way junction (3WJ). (A) (i) Secondary
structure of the phi29 pRNAmonomer with the pRNA-3WJ outlined by the box, which connects
the helical domain to the interlocking procapsid binding domains. (ii) Secondary structure and
sequence of the pRNA-3WJ and (iii) the crystal structure of the pRNA-3WJ. (B) Assembly gel of
the pRNA-3WJ from the three short RNA oligo strands on 12% native PAGE. The 3WJ (lane 7)
shows efficiency of folding and particle homogeneity before purification.
Three-component kinetics of Phi29 pRNA-3WJ
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3WJ (Binzel et al. 2014). From the association and melting
profiles in the thermodynamic studies, a single transition
step was seen, hinting to the pRNA-3WJ folding in a single
step of all three strands. Furthermore, there was no evidence
of a dimer intermediate in the 3WJ formation.
The understanding of the mechanism of assembly of the
pRNA-3WJ and the interaction of the RNA strands is of fun-
damental importance, but the study of three-component col-
lisions has not been well-studied in chemistry, biology, or
material sciences. Here, we investigated the kinetic properties
of the pRNA-3WJ using surface plasmon resonance (SPR)
to study its association and disassociation using bottom-up
RNA construction nanotechnics. We provided real-time
examination of the three-component collision of the
pRNA-3WJ. Through these studies, the pRNA-3WJ proves
to be ultrastable and only disassociates at extremely low con-
centration, which is atypical to other well-studied double-
stranded RNA or dimeric macromolecules. Furthermore,
the pRNA central motif relies heavily on each of the three
strands for rapid folding and slow dissociation rates.
RESULTS AND DISCUSSION
Determination of kinetic parameters of the pRNA-3WJ
The Bio-Rad ProteOn XPR36 allows for real-time monitor-
ing and analysis of molecule association and dissociation.
SPR allows for examination of interactions between mole-
cules on a prism surface. In this case, the ligand RNA strand
is bound through a biotin label to the neutravidin-labeled
chip surface. As mass accrues or decreases on the chip sur-
face either by ligand labeling or interactions between the
ligand and analyte, the angle of light refraction through the
chip prism and resonance is changed, thus creating a re-
sponse that then can be fit with kinetic models. The Bio-
Rad ProteOn XPR36 system allows for the observation of
36 interactions at the same time while including controls of
ligand and analyte free spots, thus providing a platform for
elaborate studies of the association and dissociation of the
pRNA-3WJ. Through real-time analysis, we are able to calcu-
late the dissociation constant (KD) by measuring the rates of
reactions moving toward 3WJ complex formation and disso-
ciation to single RNA strands.
Through classic definitions of kinetics, all chemical reac-
tions are viewed to reach equilibrium where there is a balance
in the production of products and reactants. In the case of the
pRNA three-way junction, a single-step chemical reaction is
described by Equation 1 below:
3WJa + 3WJb + 3WJc −−−−
ka
kd
3WJ (1)
and the rate of forming pRNA-3WJ can be written as
d[3WJ]
dt
= ka[3WJa][3WJb][3WJc] − kd[3WJ], (2)
where ka is the rate constant of the pRNA-3WJ formation,
and kd is the rate constant of dissociation into individual
RNA strands in units of M−2 s−1 and s−1, respectively. At
equilibrium, the rates of forward and backward reactions
are equal to each other, creating a balance between formation
of the pRNA-3WJ and single-stranded RNA. Together, the
two rate constants can be combined to define the disassocia-
tion and association constants.
KD = kd
ka
and KA = ka
kd
. (3)
Based on previous experiments (Binzel et al. 2014), it was
believed that the pRNA-3WJ was undergoing a single associ-
ation and dissociation step following what is seen in Equa-
tions 1 and 5 (Shu et al. 2011a; Binzel et al. 2014). Using
SPR, association and disassociation of the pRNA-3WJ was
examined using the 3WJa strand immobilized onto the chip
surface, hence acting as the ligand, followed by co-injecting
3WJb and 3WJc strands, acting as analytes. A single transition
is seen in the association over a range of concentrations from
20 μM to 78 nM. Based on the previous idea that the pRNA-
3WJ formed in a single step from the three components, the
data were fit to a Langmuir three-component pseudo-first-
order model using Equation 5, solving for the reaction rate
constants (Fig. 2A,B). In these experiments, a relatively cons-
tant dissociation averaged 4.52 × 10−5 s−1; this value is within
expected range for biological samples. However, the associa-
tion rate constant of the pRNA-3WJ was seen changing on
order of magnitudes, meaning a constant association rate
across tested concentrations of 20–0.078 μM. This clearly ne-
gates first-order chemical reactions and indicates error in the
assembly kinetic parameters, as one would expect the reac-
tion rate to change with varying concentration leading to a
constant ka.
KD calculation of pRNA-3WJ dimers
In order to confirm RNA/RNA interactions on the SPR chip
were in fact the formation of the 3WJ, dimers of the pRNA-
3WJ were tested and assembled (Table 1; Fig. 3). In each of
the dimer interactions (3WJab, 3WJac, and 3WJbc), associa-
tion and dissociation periods were produced. Furthermore,
once the data were fit with a pseudo-first-order Langmuir
model due to the expected 1:1 interaction between ligand
and analyte, it was seen that each of the calculated kas and
kds produced were constant and concentration independent
as expected by kinetics. This means the pRNA-3WJ dimers
were forming properly on the chip surface. Interestingly, in
comparing the association rate constants of each of the dimer
species, the 3WJbc dimer produced the most rapid “on” rate
with a ka of 1.37 × 10
5M−1 s−1; this is nearly an order of mag-
nitude higher than either the 3WJab or the 3WJac dimers.
Here the association rate constant changes units to M−1 s−1
as only two components are interacted, whereas before three
components were fused, resulting in the M−2 s−1 unit. This
Binzel et al.
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increase in association rate may be due to less internal struc-
turing of the 3WJc strand, as we see no ethidium bromide
staining of the single strand, thus giving a better diffusion
to the 3WJb compared to the 3WJa forming the 3WJab dimer
(Fig. 1A). In comparing the dissociation rate constants (kd) of
the dimers, the 3WJab dimer is seen to be the most stable
(6.78 × 10−5 s−1), followed by 3WJac with a kd of 6.34 ×
10−4 s−1, and finally the weakest dimer being the 3WJbc
(3.95 × 10−3 s−1). This indicates that the 3WJbc dimer not
only would form the quickest but also dissociates the most
rapidly. Additionally, out of concern
that the biotin end label on the ligand
RNA interfered or altered the binding
of RNA complexes on the SPR chip sur-
face, duplicate studies of dimer interac-
tions were completed by switching the
ligand strand to analyte and analyte to li-
gand through changing the biotin label to
the second strand. Through these inter-
actions no obvious change in association
profiles or ka values were seen indicating
the biotin label allows for the binding
of the ligand strand to the chip surface,
showing no significant effect on RNA
folding.
Next, in hopes of gaining insight into
the assembly mechanism of the pRNA-
3WJ, the association rates of the dimer
species were compared with the associa-
tion rate of the tested three-component
one-step reaction of the pRNA-3WJ.
This was completed by calculating con-
centration-independent association rates
(ka
′) by taking the fitted rate constants
and multiplying by the concentration of
the studied interaction resulting in an
s−1 unit (Table 2). It is important to
note that the pRNA-3WJ was multiplied
by a concentration squared value while
dimers only by concentration, due to
the difference in association reaction
orders. Surprisingly, it is seen that the
pRNA-3WJ produces a rate of reaction
on average an order of magnitude below
the 3WJbc dimer. This indicates that the
formation of the dimer species is occur-
ring before the formation of the pRNA-
3WJ, thus creating an intermediate step that was previously
not seen in thermodynamic studies (Binzel et al. 2014).
Determination of time constants of each
pRNA-3WJ strand
To further gain insight into the formation of a dimer species,
time-based strand displacement was completed on each of
the individual pRNA-3WJ strands. Using a time-based strand
replacement electrophoretic mobility shift assay (EMSA),
FIGURE 2. SPR of the pRNA-3WJ. (A) Assembly of the 3WJ of three-component strands. 5′-
Biotin-labeled 3WJa was first immobilized to the SPR chip surface. 3WJb and 3WJc strands
were mixed at equal, varying concentrations, ranging from 20 μM to 78 nM, and injected across
the chip surface for 330 sec (association phase). Following the interaction of the 3WJ strands,
blank TMS buffer was injected across the chip surface for 2700 sec (dissociation phase). The as-
sociation and dissociation curves were fit using a three-component pseudo-first-order model. (B)
Calculated kinetic parameters from SPR curve following a three-component pseudo-first-order
kinetic model. (C) SPR assay for pRNA-3WJ under the assumption of previous dimer formation
data. 5′-Biotin-labeled 3WJa was first bound to the SPR chip surface. 3WJb and 3WJc strands were
mixed at equal, varying concentrations, ranging from 20 μM to 78 nM, and were injected across
the chip surface for 660 sec followed by blank TMS buffer for 2700 sec. Association and dissoci-
ation curves were fit using a two-component pseudo-first-order model. (D) Kinetic parameters
from SPR curves following a two-component pseudo-first-order kinetic model.
TABLE 1. Kinetic parameters of pRNA-3WJ dimer species
Ligand Analyte ka (M
−1 s−1) ka error kd (s
−1) kd error KD (M) KA (M
−1)
3WJb 3WJa 4.18 × 10
4 2.55 × 102 6.78 × 10−5 2.71 × 10−7 2.30 × 10−9 6.73 × 108
3WJc 3WJa 3.59 × 10
4 1.37 × 103 6.34 × 10−4 8.86 × 10−6 2.71 × 10−8 6.17 × 107
3WJb 3WJc 1.37 × 10
5 6.31 × 103 3.95 × 10−3 1.95 × 10−5 2.88 × 10−8 3.49 × 107
Three-component kinetics of Phi29 pRNA-3WJ
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time constants were calculated for each of the RNA strands in
order to examine which, if any, of the strands is responsible
for the fast folding that has been seen in the pRNA-3WJ
and the stability at high and low concentrations. The results
show that the 3WJa and 3WJb strands produce a similar τ of
38.89 min and 35.93 min, respectively, while the 3WJc
showed a τ of only 11.81 min (Fig. 4). The longer times for
the 50% strand replacement of the 3WJa and 3WJb strands
suggest that the structure and property of the 3WJc strand
is special and unique. Using ethidium bromide or SYBR-
green staining within gels, the 3WJc is undetectable, whereas
both 3WJa and 3WJb are detected, indicating a lack in internal
structuring of the 3WJc strand (Shu et al. 2011b). From these
studies, it was determined that 3WJa and 3WJb strands are es-
sential for the strong stability of the
pRNA-3WJ motif; however, the high re-
activity of the 3WJc strand allows for
the rapid association seen in SPR studies
and previous thermodynamic studies
(Binzel et al. 2014). These results further
confirm and support the SPR dimer
studies showing a rapid rate of reaction
from the 3WJc-containing dimers with
a strong stability or dissociation of the
3WJab dimer species.
Association mechanism
of the pRNA-3WJ
The previous thermodynamic studies on
the pRNA-3WJ showed that the three
RNA fragments associated very rapidly
and the formation of a dimer interme-
diate was undetected. While a one-step
association between the three strands
seemed unlikely, it was believed that the
pRNA-3WJ formed through the initia-
tion of a pseudo-dimer with a very rapid
addition of the third RNA strand. Here
we have found that in fact the 3WJb and
3WJc strands form a dimer species at a
rapid rate and faster than the modeled as-
sociation as three strands together. Thus,
the two analytes (3WJb and 3WJc) were forming into a dimer
complex before reaching the chip surface and being able to
interact with the 3WJa ligand strand on the chip surface.
With this idea the pRNA-3WJ data were reanalyzed to follow
a pseudo-first-order reaction that would result in an assem-
bly mechanism of 3WJb + 3WJc↔ 3WJbc + 3WJa↔ 3WJabc
(Fig. 2C,D). Here the same dissociation rates were observed
as in the three-component, one-step system. Additionally,
the rates of association were independent of concentrations
tested, leading to varying rate constants. This again negates
first-order reaction laws; however, the varying rate of associ-
ation constants can be attributed to using a range of working
concentrations and thus was observed kas several orders
of magnitude above the real association rate constant. This
FIGURE 3. SPR assay for pRNA-3WJ dimers. Dimer species that make up the pRNA-3WJ were
examined through SPR at varying concentrations ranging from 20 μM to 78 nM. The injected
RNA strand was injected for 660 sec (association phase) followed by blank TMS buffer for
2700 sec (dissociation phase). The histographs were then fit using a two-component pseudo-
first-order Langmuir model for bound 5′-biotin 3WJb and 3WJa (A), bound 5′-biotin 3WJb
and 3WJc (B), bound 5
′-biotin 3WJc and 3WJa (C).
TABLE 2. Association and dissociation rates of pRNA-3WJ and its components
ka′ (s
−1)a kd (s
−1) (×10−3)
Ligand 3WJb 3WJc 3WJb 3WJa 3WJb 3WJc 3WJb 3WJa
Analyte 3WJa 3WJa 3WJc 3WJb + 3WJc 3WJa 3WJa 3WJc 3WJb + 3WJc
Concentration 5.00 × 10−6 0.0846 0.0502 0.650 0.0138 0.0850 0.601 3.25 0.0424
1.25 × 10−6 0.0415 0.0312 0.185 0.0121 0.0715 0.679 4.45 0.0477
3.10 × 10−7 0.0152 0.0129 0.0414 0.00685 0.0550 0.378 3.99 0.0461
7.80 × 10−8 0.00533 0.00567 0.0105 0.00606 0.0598 0.879 4.11 0.0491
aConcentration-independent association rates were calculated by multiplying fit association rate constants (ka) by their concentrations.
Binzel et al.
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means that the rate of the reaction for the 3WJbc + 3WJa↔
3WJabc is occurring much quicker than the observable level
on SPR and the required concentrations needed to slow the
reaction to an observable level would be too low to be sensed
on the SPR chip surface. This situation differs from the pre-
vious changing association rate constants seen in the one-step
association fitting due to the fact that here we know from the
timing scale and the dimer studies that the 3WJbc dimer is
forming before the two strands are able to interact with the
3WJa ligand bound to the chip. This leads to a simple 1:1 in-
teraction of the 3WJa ligand with the 3WJbc dimer flowing
across the chip. Additionally, through electrophoresis stud-
ies, a 1:1:1 interaction is always seen further supporting the
Langmuir model used in the SPR studies.
Therefore, it is proposed that the pRNA-3WJ undergoes a
two-step reaction, in which the second reaction takes place
immediately following the formation of the dimer intermedi-
ate at a rate that is too fast to currently quantify on SPR (Fig.
5). This high reaction rate is due to the fact that the initiation
of 3WJbc formation increases the number of bases for binding
from eight or nine bases from the single strand to 17 bases on
the duplex for interaction with the 3WJa strand (Fig. 5, mid-
dle panel). This increase in bases results in a higher probabil-
ity of reaction per collision between the RNA dimer and the
third strand, giving a significantly increased rate. Further-
more, this increase in base-pairing from 8 to 17 nucleotides
(nt) significantly lowers the Gibbs free energy of formation
(ΔG°), indicating the reaction will occur more spontane-
ously. With the increase of nucleotides
upon formation of the 3WJbc, the 3WJa
is recruited to form the completed 3WJ
with a much higher affinity. Thus, this
second high-speed reaction relies on the
formation of the 3WJbc dimer that is
the rate-limiting factor for 3WJ assembly.
Additionally, due to the rapid reaction of
the second step, only a low concentration
of the dimer intermediate is needed to
drive the 3WJ assembly. Thus, to the na-
ked eye the assembly of the pRNA-3WJ is
seemingly a singular step reaction with-
out the evidence of an intermediate step.
Furthermore, each strand and helical
region of the pRNA-3WJ plays an impor-
tant role in rapid formation and high
stability. As discussed earlier, from the
τ values we know that the 3WJc strand
is highly reactive; this results in the high-
est ka of the 3WJbc dimer. Although the
dimer between the 3WJb and the 3WJc
strands forms the quickest, it also dis-
plays the shortest dissociation rate,
showing that the pRNA-3WJ stability
is provided through the other helical
domains. The 3WJa and 3WJc strands
provide the high stability of the 3WJ, as shown in their
long half-lives and the slow kd seen in SPR studies of the
3WJab. However, although the pRNA-3WJ relies heavily on
the 3WJab helix region for its stability, the pRNA-3WJ itself
is the most stable motif, as shown in having the slowest
“off” rate (kd) (Table 2). This can be attributed to the fact
that if one helical region of the pRNA-3WJ breaks, the local
concentration of the strand is very high compared to what
would be seen in solution, thus initiating an immediate re-
folding of that helical region as the second half of the strand
is still attached to the pRNA-3WJ. As a result of these kinetic
studies, the high association rate and slow dissociation rate of
the pRNA-3WJ result from contributions of each of the RNA
strands, leading to a three-component collision.
Conclusions
The pRNA-3WJ formation follows a two-step assemb-
ly mechanism of 3WJb + 3WJc↔ 3WJbc + 3WJa↔ 3WJabc.
The 3WJbc dimer formation is the first step, occurring at
a slower and less dynamic rate, while the formation of the
pRNA-3WJ occurs at a much faster rate since each of
the two-component pairs only contain 8 nt for complemen-
tation. While assembly of each dimer resulted in an uninter-
rupted 17 nt sequence, the third complementary component
locks the unstable 3WJbc complex into a highly stable 3WJabc.
It is suggestive that dimeric intermediates might produce the
3WJabc at a fast rate, and formation of any pair of dimers can
FIGURE 4. Time constants of 3WJ strands by electrophoretic mobility shift assays (EMSA). The
half-life of each 3WJ strand in the pRNA-3WJ was calculated by EMSA using 32P-labeled free
strands, replacing unlabeled strands on assembled pRNA-3WJ. The transition of monomer to
3WJ was then plotted, and the data were fitted to calculate τ. (A) 3WJa, (B) 3WJb, and (C) 3WJc.
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promote a fast assembly with the third components to pro-
duce the 3WJabc when all three strands are incubated in the
solution. Additionally, this mechanism relies on having a bal-
anced concentration of the pRNA-3WJ strands. Thus the
pRNA-3WJ shows extraordinary stability and ease of forma-
tion, resulting in a branched motif that can be used for the
construction of stable RNA nanoparticles.
MATERIALS AND METHODS
Oligonucleotides and assembly of 3WJs
The pRNA-3WJ was constructed from three RNA oligo fragments.
RNA strands were produced by Integrated DNA Technologies
(IDT). Assembly of the pRNA-3WJ was completed by mixing
each of the three RNA strands (3WJa, 3WJb, 3WJc) at equal molar
concentrations at room temperature in TMS buffer (50 mM Tris
pH 8.0, 100 mM NaCl, 10 mM MgCl2). Samples were then run
on a 12% native polyacrylamide gel at 100 V for 2 h at 4°C in
TBM running buffer (89 mM Tris, 200 mM borate acid, and 5
mM MgCl2) to ensure pRNA-3WJ size and folding.
SPR studies of the pRNA-3WJ
The Bio-Rad ProteOn XPR36 was used to complete real-time inter-
action studies of the pRNA-3WJ motif. A neutravidin-coated
HLC chip (Bio-Rad) was used to immobilize one of the three 3WJ
strands with a 5′ biotin label. Several studies were completed by
immobilizing the 3WJa and 3WJc strands to the chip surface, fol-
lowed by injection and interaction of the remaining two 3WJ
strands. All studies were conducted at room temperature and in
TMS buffer (50 mM Tris, pH 8.0, 100 mM NaCl, 10 mM MgCl2)
with added 0.1% Tween. RNA strands were injected at a concentra-
tion ranging from 20.0 μM to 78.0 nM at a constant flow rate of 25
μL/min for a total of 660 sec. This assures the analyte RNAs are in
high excess in the association phase followed by injection of blank
TMS buffer for 2700 sec at 25 μL/min in the dissociation phase.
Real-time association and dissociation was observed and displayed
in a histograph of total response (relationship
on mass on chip surface) and time.
SPR studies of the pRNA-3WJ dimers
Utilizing a similar approach as the pRNA-
3WJ, the formation and dissociation of di-
mers from the pRNA-3WJ were analyzed. In
order to remain consistent with the studies,
the same concentration gradients were used
to examine the formation of two of the three
strands coming together within the three-way
junction.
Kinetic modeling of surface
plasmon data
Data were extracted from the Bio-Rad Pro-
teOn XPR36 and modeled using Igor Pro
6.37. The association periods of the SPR plots
were modeled using a Langmuir pseudo-first-order model consist-
ing of two and three components using Equations 4 and 5, respec-
tively. These models were selected due to the nature of SPR studies,
in that we are observing a 1:1 interaction (thus Langmuir) in which
the interacting strand is in large excess to the bound strand, creating
a pseudo-first-order interaction. The dissociation of all RNA motifs
was modeled using a Langmuir zero-order reaction as shown in
Equation 6.
R = ka[3WJa]oRmax
ka[3WJa]o + kd
(1− e−(ka[3WJa]o+kd)(t−to)), (4)
R = ka 3WJa[ ]
2
oRmax
ka 3WJa[ ]2o+kd
(1− e−(ka 3WJa[ ]2o+kd)(t−to)), (5)
R = Roe−kd(t−to), (6)
where R is the SPR response in terms of t, time in seconds. These ki-
netic models are derived in the Supplemental Material. In fitting the
data, the global fitting package was used in linking the association
and dissociation of each sample through the kd and Rmax and Ro.
Calculation of time constant (τ) of pRNA-3WJa,
3WJb, and 3WJc
The time constant (τ) of the pRNA-3WJ core strand was determined
through electrophoresis mobility shift assays (EMSA). A single
strand of the pRNA-3WJ fragments was radiolabeled at the 5′-termi-
nus using γ-32P ATP (PerkinElmer) and denoted with an asterisk, as
previously described (Binzel et al. 2014). The radiolabeled oligo was
held at a constant concentration of 10 nM and incubated over vary-
ing time points ranging from 0 to 720 min with completed pRNA-
3WJ structure at 100 nM concentrations. Samples were snap frozen
on dry ice and then an electrophoresis 12% native polyacrylamide
gel at 100 V for 2 h at 4°C in TBM running buffer was run. The
gel was then imaged by transferring the radio signal to a phosphor
screen for 12 h at −80°C and visualized using a Typhoon 7000
(GE). Band quantification was completed using ImageJ. The ratio
of single strand to 3WJ was then calculated and plotted against
time in OriginPro 8.5. The curve was fit using Equation 7 below:
[3WJx] = [3WJx]oe−t/t, (7)
FIGURE 5. Assembly mechanism of pRNA-3WJ. The pRNA-3WJ assembles through a two-step
association mechanism in which the 3WJbc dimer first forms, as shown in the first panel. This
association step greatly increases the attraction of the 3WJa strand through the doubling of nucle-
otides presented for binding resulting in a dropped ΔG°. This second reaction occurs at an un-
observable rate and results in forming a stable nanostructure, in which each of the three
strands is locked into the structure by two areas of base-pairing.
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where t is the time in seconds, and τ is the time constant at which
50% of the labeled 3WJ strand was in single-strand state and 50%
had replaced unlabeled strand in the 3WJ complex (Novikova
et al. 2010). These studies were completed as a way to compare
the strand displacement between each of the pRNA-3WJ strands.
SUPPLEMENTAL MATERIAL
Supplemental material is available for this article.
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